JAMA neurology
October 12, 2026 · via Europe PMC
Global Incidence of All-Cause Dementia: A Meta-Analysis.
Vella AS, Visontay R, Lipnicki DM, +45 more, Cohort Studies of Memory in an International Consortium (COSMIC).
AI summary — for doctors, generated from the abstract only
Global dementia incidence was 9.7 per 1000 person-years, higher in women and in low- and middle-income countries, with 24.7 million projected new cases in 2050 if incidence stays constant.
What was studied
Individual participant-level meta-analysis of 22 COSMIC population-based cohorts (N = 38,418) in 18 countries or territories, estimating age- and sex-standardized dementia incidence with Poisson models.
Key findings
- Across 287,632 person-years at risk, 3001 participants developed dementia; standardized incidence was 9.7 (95% CI 7.89-11.97) per 1000 person-years
- Incidence was higher in women (10.6) than men (8.6) and in low- and middle-income countries (13.6) than high-income countries (8.3)
- Applying rates to the 2050 population projected 24.7 million new cases, assuming constant incidence
Clinical relevance
Provides a benchmark for planning diagnostic and care services, especially in under-studied regions.
Who should care
Limitations
Cohorts began recruitment between 1990 and 2011 with varying methods, projections assume constant incidence, and wide confidence intervals persist.
Dementia incidence is substantial and higher in women and lower-income settings.
This is an AI-generated summary of the published abstract, not a clinical recommendation. It may not reflect the full text or subsequent updates — verify against the original source before acting on it.
Abstract
Importance
Global dementia incidence estimates are limited by underrepresentation of low- and middle-income countries and heterogeneous analytic methods. Due to these limitations, true understanding of the global dementia landscape remains incomplete.
Objective
To identify dementia incidence rates by age and sex in various regions worldwide (high-income countries and low- and middle-income countries) where data on clinically based dementia diagnoses were available.
Data sources
Retrospective community-based cohorts from the Cohort Studies of Memory in an International Consortium (COSMIC); baseline recruitment commenced between January 1990 and December 2011 and follow-up data were collected through the end of 2021. Data were analyzed from June 2024 to June 2025.
Study selection
Eligible studies included longitudinal COSMIC cohort studies with a clinically based diagnosis of dementia. Individual participant-level data from 22 population-based longitudinal cohorts (N = 38 418) spanning 18 countries or territories across 6 continents were included.
Data extraction and synthesis
Data extraction and assessment of study quality and validity were conducted according to Meta-Analyses of Observational Studies in Epidemiology (MOOSE) guidelines. Individual participant-level data were meta-analyzed in a 2-step process using random intercepts for country and study at the global and regional levels and by country income level.
Main outcomes and measures
For each study with a clinically based diagnosis, incidence rates for all-cause dementia were calculated and a 2-step meta-analysis was conducted. Using a person-years at risk framework with inverse-probability censoring weights and Poisson models, age- and sex-specific incidence were estimated and then standardized to the 2023 global age-sex population structure.
Results
Across 287 632 person-years at risk, 3001 participants developed dementia. Age- and sex-standardized incidence was 9.7 (95% CI, 7.89-11.97) per 1000 person-years at risk. Age-standardized incidence was higher in women than men (10.6; 95% CI, 8.61-13.11 vs 8.6; 95% CI, 6.94-10.72). Standardized incidence was higher in low- and middle-income countries (13.6; 95% CI, 9.67-19.24) than in high-income countries (8.3; 95% CI, 6.57-10.54). Applying age- and sex-specific rates to the projected 2050 population yielded a projected 24.7 million new cases, assuming constant incidence over time.
Conclusions and relevance
The harmonized estimates presented in this study provide a comparable benchmark for global dementia incidence and inform planning for prevention, diagnosis, and memory-care services, particularly in underrepresented low- and middle-income country settings.
DOI
10.1001/jamaneurol.2026.3540
PMID
42862582
Research metadata (titles, abstracts, authors, publication dates) is sourced from Europe PMC, which aggregates content from PubMed/MEDLINE, PubMed Central, and other providers under the U.S. National Library of Medicine (NLM/NCBI). NLM does not claim copyright on abstracts; the original journal publishers or authors may hold rights to the full articles. AI-generated summaries are derived only from the abstract, never the full text, and are always labeled as AI-generated.
Want more like this?
Browse more from the feed. A free account unlocks the full feed, saving and communities.
Back to the research feed